Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun;17(3):258-262.
doi: 10.7861/clinmedicine.17-3-258.

Adrenal insufficiency - recognition and management

Affiliations
Review

Adrenal insufficiency - recognition and management

Agnieszka Pazderska et al. Clin Med (Lond). 2017 Jun.

Abstract

Adrenal insufficiency is characterised by inadequate -glucocorticoid production owing to destruction of the adrenal cortex or lack of adrenocorticotropic hormone stimulation. In primary adrenal insufficiency, lack of mineralocorticoids is also a feature. Patients can present with an insidious onset of symptoms, or acutely in adrenal crisis, which requires prompt recognition and treatment. Chronic glucocorticoid therapy is the most common cause of adrenal insufficiency. The -diagnosis of adrenal insufficiency is made by -demonstrating low basal and/or stimulated serum cortisol and should be -followed by appropriate investigations to establish the -underlying aetiology. Maintenance glucocorticoid -replacement is usually given as a twice or thrice daily hydrocortisone preparation. Patients with primary adrenal insufficiency also require mineralocorticoid. Regular monitoring for features of under- and over- replacement is essential during follow-up. Patient education is a key feature of management of this condition.

Keywords: ACTH; adrenal insufficiency; adrenocorticotropic hormone; glucocorticoid.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Algorithm for the initial investigation of adrenal insufficiency. +ve = positive; -ve = negative; Abs = antibodies; ACTH = adrenocorticotropic hormone; CT = computerised tomography; MRI = magnetic resonance imaging

References

    1. van Staa TP. Leufkens HG. Abenhaim L, et al. Use of oral ­corticosteroids in the United Kingdom. QJM. 2000;93:105–11. - PubMed
    1. Tomlinson JW. Holden N. Hills RK, et al. Association between ­premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet. 2001;357:425–31. - PubMed
    1. Gibb FW. Stewart A. Walker BR. Strachan MW. Adrenal insufficiency in patients on long-term opioid analgesia. Clin Endocrinol. 2016;85:831–5. - PubMed
    1. Løvås K. Husebye ES. High prevalence and increasing incidence of Addison's disease in western Norway. Clin Endocrinol. 2002;56:787–91. - PubMed
    1. Winqvist O. Karlsson FA. Kämpe O. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet. 1992;339:1559–62. - PubMed

MeSH terms